Abstract
We are interested in developing oncolytic adenoviruses for the treatment of prostate cancer (PCa) bone metastases. A key limitation of Adenovirus 5 (Ad5) is that upon systemic administration, it produces major liver and systemic toxicities. To address this issue, a chimaeric Ad5/48 adenovirus mHAd.sTβRFc was created. Seven hypervariable regions of Ad5 hexon present in Ad5-based Ad.sTβRFc expressing soluble transforming growth factor beta receptorII-Fc fusion protein (sTGβRIIFc), were replaced by those of Ad48. mHAd.sTβRFc, like Ad.sTβRFc, was replication competent in the human PCa cells, and produced high levels of sTGβRIIFc expression. Compared to Ad.sTβRFc, the systemic delivery of mHAd.sTβRFc in nude mice resulted in much reduced systemic toxicity, and reduced liver sequestration. Ad.sTβRFc produced significant liver necrosis, and increases in alanine transaminase, aspartate transaminase, lactate dehydrogenase, tumor necrosis factor-α, and interleukin-6 levels, while mHAd.sTβRFc produced much reduced responses of these markers. Intravenous delivery of Ad.sTβRFc or mHAd.sTβRFc (5 × 10 10 viral particles/mouse) in nude mice bearing PC-3-luc PCa bone metastases produced inhibition of bone metastases. Moreover, a larger dose of the mHAd.sTβRFc (4 × 10 11 viral particles /mouse) was also effective in inhibiting bone metastases. Thus, mHAd.sTβRFc could be developed for the treatment of PCa bone metastases.
Original language | English (US) |
---|---|
Pages (from-to) | 1504-1517 |
Number of pages | 14 |
Journal | Molecular Therapy |
Volume | 22 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2014 |
Funding
The work was funded in part by the National Institutes of Health grant # R01CA12738 (P.S.), and philanthropic support through John and Carol Walter Center for Urological Health , NorthShore University HealthSystem . Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences , under Contract No. DE-AC02-06CH11357 . We are thankful to the Kovler Family Foundation, and Richard Hulina, Jimmie Alford and Maree Bullock, and an anonymous donor for their generous philanthropic support. We are thankful to Janardan Khandekar, Theodore Mazzone, Bruce Brockstein and Michael Caplan for their continuous support. This work is dedicated to the fond memory of Jimmie Alford.
ASJC Scopus subject areas
- Drug Discovery
- Genetics
- Molecular Medicine
- Molecular Biology
- Pharmacology